Fluorenol, also known as hydrafinil,[2] is an alcohol derivative of fluorene. In the most significant isomer, fluoren-9-ol or 9-hydroxyfluorene, the hydroxy group is located on the bridging carbon between the two benzene rings. Hydroxyfluorene can be converted to fluorenone by oxidants. It is a white-cream colored solid at room temperature.
| Names | |
|---|---|
| IUPAC name
9H-Fluoren-9-ol | |
| Other names
9-Hydroxyfluorene | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.015.345 |
| EC Number |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C13H10O | |
| Molar mass | 182.22 g/mol |
| Appearance | Off-white crystalline powder |
| Density | 1.151 g/mL |
| Melting point | 152 to 155 °C (306 to 311 °F; 425 to 428 K) |
| Practically insoluble[1] | |
| Hazards | |
| NFPA 704 (fire diamond) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Toxicity
editFluorenol is toxic to aquatic organisms including algae, bacteria, and crustaceans.[3] Fluorenol was patented as an insecticide in 1939,[4] and is an algaecide against the green algae genera Dunaliella.[5]
Toxicity and carcinogenicity in humans are unknown.[5]
Mechanism of action
editEugeroic
editA study published by Cephalon describing research to develop a successor to the eugeroic modafinil reported that the corresponding fluorenol derivative was 39% more effective than modafinil at keeping mice awake over a 4-hour period.[10] However, after further investigation it was determined that the eugeroic activity of the fluorenol analog was likely due to an active metabolite, which they identify as fluorenol itself.[10] Fluorenol is a weak dopamine reuptake inhibitor with an IC50 of 9 μM, notably 59% weaker than modafinil (IC50 = 3.70 μM),[10] potentially making it even less liable for addiction.[11] It also showed no affinity for cytochrome P450 2C19, unlike modafinil.[10]
There is no evidence (binding assays, occupancy, predicted structure) to suggest that fluorenol acts on serotonin receptors, contrary to some popular claims.[medical citation needed]
Sale as research chemical
editThe unscheduled nature of fluorenol has caused it to fall into a legal grey area in most countries. Despite being associated with modafinil,[12] fluorenol is not a substituted derivative of it, making its scheduling unimplied by analogue acts.
Fluorenol is a relatively obscure compound in the research chemical market. According to an online survey with over 3000 respondents, only 2% of modafinil users have reported using fluorenol.[13]
See also
editReferences
edit- ↑ Record of 9H-Fluoren-9-ol in the GESTIS Substance Database of the Institute for Occupational Safety and Health, accessed on 5 November 2008.
- ↑ Knoop, Andre; Fußhöller, Gregor; Haenelt, Nadine; Goergens, Christian; Guddat, Sven; Geyer, Hans; Thevis, Mario (November 2021). "Mass spectrometric characterization of urinary hydrafinil metabolites for routine doping control purposes". Drug Testing and Analysis. 13 (11–12): 1915–1920. doi:10.1002/dta.3137. ISSN 1942-7611. PMID 34378339. S2CID 236976954.
- ↑ Šepič, Ester; Bricelj, Mihael; Leskovšek, Hermina (2003). "Toxicity of fluoranthene and its biodegradation metabolites to aquatic organisms". Chemosphere. 52 (7): 1125–33. Bibcode:2003Chmsp..52.1125S. doi:10.1016/S0045-6535(03)00321-7. PMID 12820993.
- ↑ US patent 2197249: Insecticide
- 1 2 MSDS Archived 2016-03-04 at the Wayback Machine
- ↑ Clifford W Fong. Modafinil and modafinil analogues: free radical mechanism of the eugeroic and cognitive enhancement effect. [Research Report] Eigenenergy. 2018. ffhal-01933737f
- ↑ PubChem. "9H-Fluoren-9-ol". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-09-20.
- ↑ PubChem. "Modafinil". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-09-20.
- ↑ PubChem. "Amphetamine". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-09-20.
- 1 2 3 4 Dunn, D.; Hostetler, G.; Iqbal, M.; Marcy, V. R.; Lin, Y. G.; Jones, B.; Aimone, L. D.; Gruner, J.; Ator, M. A.; Bacon, E. R.; Chatterjee, S. (2012). "Wake promoting agents: Search for next generation modafinil, lessons learned: Part III". Bioorganic & Medicinal Chemistry Letters. 22 (11): 3751–3753. doi:10.1016/j.bmcl.2012.04.031. PMID 22546675.
- ↑ Wise, R. A. (1996). "Neurobiology of addiction". Current Opinion in Neurobiology. 6 (2): 243–51. doi:10.1016/S0959-4388(96)80079-1. PMID 8725967. S2CID 25378856.
- ↑ Dunn, Derek; Hostetler, Greg; Iqbal, Mohamed; Marcy, Val R.; Lin, Yin Guo; Jones, Bruce; Aimone, Lisa D.; Gruner, John; Ator, Mark A.; Bacon, Edward R.; Chatterjee, Sankar (2012-06-01). "Wake promoting agents: search for next generation modafinil, lessons learned: part III". Bioorganic & Medicinal Chemistry Letters. 22 (11): 3751–3753. doi:10.1016/j.bmcl.2012.04.031. ISSN 1464-3405. PMID 22546675.
- ↑ Branwen, Gwern (2015-06-01). "Modafinil community survey".
{{cite journal}}: Cite journal requires|journal=(help)


